- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Chronic Obstructive Pulmonary Disease, COPD in Japan
Total 1042 results
-
AstraZenecaMitsubishi Tanabe Pharma CorporationCompletedChronic Obstructive Pulmonary Disease (COPD)Japan
-
AstraZenecaMitsubishi Tanabe Pharma CorporationCompletedChronic Obstructive Pulmonary Disease (COPD)Japan
-
Translational Research Center for Medical Innovation...Kobe City Medical Center General HospitalCompletedChronic Obstructive Pulmonary Disease (COPD)Japan
-
Translational Research Center for Medical Innovation...Kobe City Medical Center General HospitalCompletedChronic Obstructive Pulmonary Disease (COPD)Japan
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)Japan
-
Eisai Co., Ltd.Completed
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)Taiwan, Korea, Republic of, Japan, India, Hong Kong, Singapore
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)Japan
-
AstraZenecaCompletedCOPDKorea, Republic of, Malaysia, Taiwan, Hong Kong, Philippines
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Russian Federation, Taiwan, Canada, Germany, Philippines, South Africa, Spain, United Kingdom, Turkey, Hungary, Guatemala, Australia, Bulgaria, France, Poland, Switzerland, Slovakia, Japan
-
AstraZenecaRecruitingChronic Obstructive Pulmonary Disease (COPD)United States, Canada, Czechia, Denmark, Hungary, Netherlands, Spain, Korea, Republic of, Argentina, Belgium, Bulgaria, Finland, India, Japan, Mexico, Norway, Sweden, Turkey, Vietnam, Portugal, Puerto Rico
-
AstraZenecaRecruitingChronic Obstructive Pulmonary Disease (COPD)China, Denmark, United States, Australia, Germany, Netherlands, Poland, Spain, United Kingdom, Korea, Republic of, Philippines, Italy, Argentina, Belgium, Bulgaria, Canada, Czechia, Finland, Hungary, India, Japan, Mexico, Norway, Port... and more
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseBelgium, France, Japan
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)Germany, Colombia, India, Korea, Republic of, Poland, Romania, South Africa, Italy, Austria, Belgium, Croatia, Estonia, Hungary, Russian Federation, Taiwan, Turkey, Japan, Spain, Sweden, United Kingdom, China, Thailand, Canada, Hong Kong and more
-
AstraZenecaRecruitingChronic Obstructive Pulmonary Disease (COPD)China, United States, Denmark, Italy, Canada, Germany, Hungary, Netherlands, Spain, United Kingdom, Belgium, Argentina, Bulgaria, India, Japan, Vietnam, Malaysia, Thailand, Korea, Republic of, Mexico, Brazil, Greece, Poland, France, Peru, Chil... and more
-
NovartisCompletedChronic Obstructive Pulmonary DiseaseJapan
-
AstraZenecaRecruitingCOPD (Chronic Obstructive Pulmonary Disease)France, Denmark, Italy, Spain, United States, Canada, Argentina, Japan, Colombia, Germany, Peru, Brazil, China, India, Thailand, Austria, Serbia, Malaysia, Philippines, Poland, Taiwan, Greece, Norway, Sweden, Mexico, Romania, Korea, Republic... and more
-
Pulmonx CorporationRecruiting
-
Eisai Co., Ltd.CompletedChronic Obstructive Pulmonary Disease | AsthmaJapan
-
Hoffmann-La RocheRecruitingChronic Obstructive Pulmonary Disease (COPD)United States, China, Spain, Italy, Belgium, Korea, Republic of, Poland, Taiwan, Israel, United Kingdom, Japan, Czechia, New Zealand, Philippines, Hong Kong, Greece, Australia, Thailand, Netherlands, Argentina, France, India, Canada, ... and more
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveJapan
-
Kindai UniversityCompletedChronic Obstructive Pulmonary DiseaseJapan
-
University of JazanCompletedChronic Obstructive Pulmonary Disease ExacerbationSaudi Arabia
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveJapan
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveJapan
-
BayerCompleted
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveJapan
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveJapan
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseJapan
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveJapan
-
Tjip van der WerfGadjah Mada University; The Enose Company, Zutphen the NetherlandsCompletedPulmonary Tuberculosis Suspected | Other Specified Chronic Obstructive Pulmonary Disease | Pulmonary Tuberculosis TB (+) Histology, (-) BacteriologyIndonesia
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveJapan
-
AstraZenecaCompleted
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveJapan
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveJapan
-
Boehringer IngelheimCompleted
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseJapan
-
AstraZenecaParexelCompletedChronic Obstructive Pulmonary Disease | Asthma | COPDUnited States, Canada, Germany, Italy, Spain, United Kingdom, Mexico, Australia, Argentina, France, China, Japan, Brazil, Korea, Republic of, Colombia, Denmark, Netherlands, Norway, Sweden
-
Otsuka Pharmaceutical Co., Ltd.CompletedChronic Obstructive Pulmonary DiseaseChina, Japan, Korea, Republic of
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseJapan
-
AstraZenecaLinical Co., Ltd.CompletedPulmonary Disease, Chronic ObstructiveJapan
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseJapan
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveJapan
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseJapan
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveJapan
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveJapan
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveJapan
-
GlaxoSmithKlineCompleted
-
AstraZenecaLinical Co., Ltd.CompletedPulmonary Disease, Chronic ObstructiveJapan
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveJapan